Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer

Acta Urologica Japonica

Volumn 52, Issue 6, 2006, Pages 433-438

  Fujimoto, Kiyohide ^a   Chihara, Yoshitomo ^a   Kondo, Hideaki ^a   Hirao, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

BCG; Conservative treatment; Grade 3 Ta 1; Superficial bladder cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BCG VACCINE;

AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; MAJOR CLINICAL STUDY; MALE; SUPERFICIAL CANCER; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 33745758588     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jakse G, Loidl W, Seeber G, et al.: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137: 39-43, 1987
2. Heney NM, Ahmed S, Flanagan MJ, et al.: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983
3. Pauwels RP, Schapers RF, Smeets AW, et al.: Grading in superficial bladder cancer. (I). Morphological criteria. Br J Urol 61: 129-134, 1988
4. Abel PD, Hall RR and Williams G: Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 62: 235-239, 1988
5. Smith JA Jr, Labasky RF, Cockett AT, et al.: Bladder cancer clinical guidelines panel summary report on the management of non-muscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J Urol 162: 1697-1701, 1999
6. Ozono S, Hinotsu S, Tabata S, et al.: Treated natural history of bladder cancer. Jpn J Clin Oncol 31: 536-540, 2001
7. Witjes JA, Kiemeney LA, Schaafsma HE, et al.: The incidence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. Br J Urol 73: 172-176, 1994
8. Richards B, Parmar MK, Anderson CK, et al.: Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC bladder cancer sub group. Br J Urol 67: 369-375, 1991
9. Hirao Y, Ozono S, Momose H, et al.: Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Cancer Chemother Pharmacol 35: 36-40, 1994
10. Herr HW: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162: 74-76, 1999
11. Pagano F, Bassi P, Galetti TP, et al.: Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45-50, 1991
12. Amling CL, Thrasher JB, Frazier HA, et al.: Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151: 31-36, 1994
13. Shahin O, Thalmann GN, Rentsch C, et al.: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence. J Urol 169: 96-100, 2003
14. Heney NM, Ahmed S, Flanagan MJ, et al.: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983
15. Griffiths TR, Charlton M, Neal DE, et al.: Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance. J Urol 167: 2408-2412, 2002
16. Gattengo B: T1G3 bladder tumours: conservative management or cystectomy. Eur Urol 45: 399-400, 2004
17. Turner W: T1G3 bladder tumours: the case for conservative treatment. Eur Urol 45: 401-405, 2004
18. Malavaud B: T1G3 bladder tumours: the case for radical cystectomy. Eur Urol 45: 406-410, 2004
19. Lamm DL, Blumenstein BA, Crissman JD, et al.: Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163: 1124-1129, 2000
20. Lamm DL, Blumenstein BA, Crawford ED, et al.: A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 325: 1205-1209, 1992
21. Herr HW: Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174: 2134-2137, 2005
22. Sylvester RJ, van der Meijden A and Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964-1970, 2002
23. Pansadoro V, Emiliozzi P, de Paula F, et al.: Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guerin: 18-year experience. Urology 59: 227-231, 2002
24. Cookson MS, Herr HW, Zhang ZF, et al.: The treated natural history of high risk superficial bladder cancer. J Urol 158: 62-67, 1997
25. Bracken RB, McDonald MW and Johnson DE: Cystectomy for superficial bladder cancer. Urology 18: 459-463, 1981
26. Stockle M, Alken P, Engelmann U, et al.: Radical cystectomy: often too late? Eur Urol 13: 361-367, 1987
27. Malkowicz SB, Nichols P, Lieskovsky G, et al.: The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, PIS and P2). J Urol 144: 641-645, 1990
28. Bianco FJ Jr, Justa D, Grignon DJ, et al.: Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 22: 290-294, 2004